Empty Nose Syndrome · comprehensive guide
Empty Nose Syndrome is a postoperative nasal disorder in which a person can have a physically open nasal cavity yet experience severe obstruction, insufficient air sensation, dryness, burning, air hunger or a disturbing sense that breathing no longer feels normal. This guide brings together the main clinical concepts, current research and areas of uncertainty without treating every proposed mechanism as proven fact.
What is Empty Nose Syndrome?
Empty Nose Syndrome, usually abbreviated ENS, is a condition most often described after surgery that reduces or removes nasal turbinate tissue. The classic complaint is paradoxical nasal obstruction: the nasal cavity may look unusually open on examination, and objective resistance can be low, yet the patient reports that breathing feels blocked, unsatisfying or frighteningly incomplete. Other commonly reported symptoms include dryness, crusting, burning, a sensation of excessive openness, reduced perception of airflow and a feeling of suffocation or air hunger.
The word empty can be misleading. ENS is not defined by a single amount of missing tissue, a particular CT appearance or one surgical technique. A person may have visibly reduced turbinates without developing ENS, while another person can report severe ENS-type symptoms after a more limited procedure. This is one reason the condition was historically difficult to understand when clinicians focused mainly on cross-sectional anatomy and airway size.
Modern ENS research therefore treats nasal breathing as a sensory and aerodynamic process rather than a simple pipe-flow problem. The brain does not determine whether the nose is “open” only by measuring resistance. It receives information from temperature-sensitive and mechanosensory pathways in the mucosa, integrates that information with respiratory drive, and interprets the pattern of airflow across different regions of the nasal cavity. Surgery can change more than lumen diameter: it can change where the air travels, how strongly it interacts with mucosa, how much cooling occurs, how moisture is exchanged and what sensory signals reach the central nervous system.
ENS remains an evolving field. Some mechanisms are supported by multiple studies, while others remain plausible hypotheses. A professional discussion of ENS should preserve that distinction. It is reasonable to say that altered airflow and impaired nasal sensation are central research themes; it is not reasonable to claim that every patient has the same nerve injury, the same blood-gas disturbance or the same systemic complication.
Why the nasal turbinates matter
The turbinates are elongated structures on the sidewalls of the nasal cavity. The inferior turbinates are the largest and are especially important in routine nasal airflow. They are covered by vascular, innervated mucosa and help create a large functional surface area within a relatively compact space. Rather than simply occupying room, they help shape how inhaled air is distributed through the nose.
During normal nasal breathing, incoming air is warmed and humidified before reaching the lower airway. On exhalation, the nasal surfaces can recover some heat and moisture. The turbinates also participate in the changing resistance of the nasal airway. Their vascular tissue can swell and decongest, contributing to the normal nasal cycle in which the two sides alternate in relative openness over time.
The nasal cavity is also a sensory organ. Trigeminal nerve pathways contribute to the perception of cooling, irritation and airflow. This helps explain a familiar everyday experience: menthol can make a nose feel more open even when it does not substantially enlarge the airway. Conversely, local anesthesia can reduce the sensation of airflow. In other words, perceived patency is partly a sensory construction.
This matters for surgery. Turbinate reduction can be useful for appropriately selected patients with persistent nasal obstruction, but the goal of contemporary tissue-sparing approaches is generally to improve airflow while preserving as much functional mucosa and turbinate architecture as reasonably possible. ENS prevention is not about refusing all turbinate surgery; it is about respecting the function of the tissue and avoiding unnecessary or excessive loss.
Why can an anatomically open nose feel obstructed?
This is the central question in ENS. Conventional intuition says that a larger airway should always feel easier to breathe through. ENS demonstrates why that model is incomplete. Objective airway size and subjective nasal patency correlate only imperfectly even outside ENS. In affected patients, widening the nasal cavity can coexist with reduced or distorted sensory feedback.
Computational fluid-dynamics studies have shown that after turbinate loss, airflow may not simply spread evenly through the newly enlarged space. In some ENS patients it forms a narrower jet directed toward the middle region of the nasal cavity, while airflow intensity and wall interaction around the inferior meatus can actually fall. This is important because tissue that remains present may receive less effective stimulation than expected from the apparent openness of the nose.
At the same time, studies of menthol detection and other trigeminal sensory measures have found impaired sensitivity in groups of ENS patients. The combination provides a coherent model: altered anatomy changes the pattern of airflow, and reduced sensory responsiveness makes the remaining airflow signal less effective. The patient can therefore have plenty of geometric space but too little useful sensory information from breathing.
This does not prove that every patient has identical nerve damage. Neural dysfunction may arise from direct injury, altered stimulation after surgery, abnormal healing, chronic dryness or a combination of mechanisms. The 2015 review by Sozansky and Houser emphasized that purely anatomical analysis is insufficient and proposed abnormal neurosensory healing as an important contributor. Later systematic reviews have continued to identify trigeminal and thermoreceptor dysfunction as a major research theme.
Airflow, mucosal cooling and TRPM8
One of the strongest physiological ideas in ENS research is that the sensation of nasal openness depends substantially on mucosal cooling. As inspired air passes over moist nasal surfaces, evaporation and heat transfer cool the mucosa. Temperature-sensitive trigeminal receptors respond to this change. Among the receptor families studied in nasal airflow perception is TRPM8, which also responds to menthol and cool temperatures.
For a healthy person, this sensory system provides continuous evidence that air is moving. If the pattern of airflow after surgery bypasses important mucosal regions, if the mucosa becomes chronically dry or altered, or if sensory responsiveness is reduced, the expected cooling signal can become weaker. The brain may then receive a mismatch between the mechanical fact that air is entering and the sensory experience that should accompany that airflow.
This framework helps explain several otherwise confusing observations. ENS patients can report improvement when a small amount of cotton is placed in the inferior meatus, even though the cotton technically narrows the airway. By redirecting airflow and increasing interaction with remaining mucosa, the temporary narrowing may improve the quality of the sensory signal. It also helps explain why some patients report that humidity, temperature and environmental conditions strongly affect symptoms.
The research does not support reducing ENS to “TRPM8 damage” alone. The systematic literature includes aerodynamic differences, histopathological changes, altered nasal nitric oxide, psychological and autonomic findings, and substantial heterogeneity between patients. TRPM8 is best viewed as part of a broader trigeminal sensory system that interacts with nasal geometry, mucosal health and respiratory perception.
For a focused review of this mechanism, see Nasal Cooling After Turbinate Surgery: Mucosal Temperature, Humidification and ENS.
Nasal cycle, resistance and why “more open” is not always better
The normal nose is not a fixed tube. Its resistance changes continuously as vascular tissue in the turbinates swells and decongests. This contributes to the nasal cycle, in which one side is usually relatively more congested while the other is more open, followed later by a gradual shift. The cycle is influenced by autonomic tone, posture, exercise, temperature, inflammation and many other factors.
This dynamic behavior is important because patients are often taught to interpret any resistance as a defect. In reality, some resistance is part of normal nasal physiology. The nose must condition inspired air, generate contact between airflow and mucosa, and provide a useful sensory signal. A completely unobstructed cavity is therefore not necessarily the physiologically ideal endpoint of surgery.
That does not mean that higher resistance is always better or that people with ENS simply need a narrow nose. Excessive resistance from allergy, turbinate hypertrophy, septal deviation or nasal valve collapse can be disabling in its own way. The point is that nasal function depends on a balanced airway: sufficient space for ventilation, enough mucosal surface and appropriate geometry for conditioning and sensation.
After turbinate surgery, resistance may be reduced substantially. In a person who improves, the new geometry can relieve obstruction while preserving adequate mucosal function. In a person who develops ENS, however, lower resistance may coexist with an unfavorable airflow pattern or reduced sensory feedback. That is why simply measuring resistance does not settle the question.
The nasal cycle can also complicate interpretation of postoperative symptoms. One side may retain more functional tissue than the other, and symptoms can change as mucosal congestion shifts between sides. Some people describe periods in which the nose feels more normal when the relatively better-preserved side is carrying more of the airflow, followed by periods of severe openness or reduced sensation when the balance changes. Such reports are plausible within normal nasal-cycle physiology, although individual mechanisms require direct examination.
Posture provides another example. Lying on one side tends to increase congestion in the dependent nasal cavity and open the upper side. For some ENS patients, a modest increase in resistance can temporarily improve the quality of airflow sensation; for others, additional congestion makes breathing worse. This variability is one reason broad statements such as “ENS means the nose is always too open” are too simplistic.
Exercise has similarly complex effects. Sympathetic activation tends to decongest the nasal mucosa, which can make the airway more open. A person with ordinary turbinate swelling may experience that as relief. A person with severe ENS can sometimes experience increased openness as less comfortable, while another may appreciate the stronger airflow and cooling generated during physical activity. The symptom response depends on anatomy, residual mucosa, airflow location, sensory function and respiratory control.
From a treatment perspective, the goal is therefore not to recreate a specific numerical resistance. The practical target is a configuration that produces tolerable breathing, adequate humidification and a useful sensory signal. Cotton testing, temporary fillers and reconstruction all exploit this idea: the clinician is testing how a change in local volume changes the quality of breathing, not merely how many pascals of resistance are added.
Why ENS differs so much between patients
One of the most important lessons from modern research is heterogeneity. Two people can undergo similar operations and have very different outcomes. Likewise, two patients with severe ENS can emphasize different symptoms: one may be dominated by dryness and burning, another by suffocation and absent airflow sensation, and another by sleep disruption or dysfunctional breathing.
Part of this variation is anatomical. The exact segment of turbinate that was reduced, whether the anterior head was preserved, whether surgery affected inferior or middle turbinate tissue, septal shape, nasal valve geometry and the amount of remaining mucosa can all influence postoperative airflow. Operative labels such as “radiofrequency reduction” or “septoplasty” do not fully describe the resulting anatomy.
Part may be sensory. Baseline trigeminal sensitivity differs between individuals, and wound healing can alter nerve function in ways that are not visible on routine endoscopy. Chronic dryness or inflammation may further change the way remaining mucosa responds to moving air. Some patients report that cooling agents or temporary airflow redirection produce a dramatic change in breathing perception, while others respond very little.
Central processing may also matter. The brain continuously compares respiratory motor activity with sensory feedback from the lungs, chest wall, upper airway and blood-gas regulation. A mismatch in one source of feedback can be experienced as dyspnea or air hunger. How strongly the nervous system weights nasal signals, and how it adapts after surgery, may differ from person to person.
Psychological and behavioral factors can modify severity without being the original cause. A patient who repeatedly experiences frightening suffocation sensations may become highly vigilant to every breath. Severe sleep loss can lower the threshold for distress and pain. Conversely, reassurance, breathing rehabilitation and better sleep can reduce amplification even when the nasal anatomy is unchanged. This interaction is clinically useful because it creates several possible treatment targets.
Comorbid nasal disease can further complicate the picture. ENS can coexist with rhinitis, sinus disease, scar formation, nasal valve collapse or septal problems. A patient may therefore have both excessive openness in one region and genuine mechanical obstruction in another. Treating only one part of that mixed physiology can produce disappointing results.
This heterogeneity explains why online patient descriptions sometimes appear contradictory. One person feels worse in dry cold air; another feels worse in warm stagnant air. One benefits from modest obstruction; another cannot tolerate additional narrowing. Those differences do not necessarily mean that one patient has ENS and the other does not. They mean that ENS is a syndrome, not a single uniform lesion.
For the same reason, outcomes after reconstruction vary. A procedure that helps one patient may fail in another because the target location, residual sensory capacity or dominant symptom mechanism differs. The increasing use of location-specific cotton testing and individualized airflow analysis is an attempt to match treatment to the patient rather than apply one operation to everyone.
What routine tests can — and cannot — tell you
People with ENS are often frustrated when ordinary tests are reported as normal. Understanding what each test measures helps explain why. A CT scan is excellent for showing anatomy: bone, sinus cavities, septal position and the amount of visible turbinate tissue. It does not directly measure whether the patient receives a normal cooling signal, how trigeminal sensation is functioning or whether the airflow pattern feels physiologically appropriate.
Rhinomanometry measures pressure and airflow and can estimate nasal resistance. This is useful when the clinical question is conventional obstruction, but low resistance does not tell us whether airflow is distributed optimally across the mucosa. In ENS, a low-resistance airway can still be symptomatic. Acoustic rhinometry similarly describes cross-sectional geometry rather than sensory quality.
Endoscopy is essential because it allows direct inspection of the mucosa, turbinate remnants, crusting, scar, valve behavior and other abnormalities. Yet even endoscopy cannot reveal all neural function. A nose can look healed while the patient reports profoundly abnormal sensation, just as skin can look normal after an injury yet have altered touch or pain sensitivity.
Oxygen saturation is another commonly misunderstood measurement. A normal pulse-oximeter reading is reassuring about arterial oxygen saturation at that moment, but it does not measure carbon dioxide and cannot diagnose or exclude hyperventilation. Conversely, the existence of a hyperventilation study in ENS does not justify assuming abnormal carbon dioxide in a patient who has never been measured.
Capnography and blood-gas analysis can evaluate carbon dioxide and acid-base status when clinically indicated. These tests become relevant when a patient has symptoms or observations suggesting dysfunctional breathing. They should be interpreted in context because values depend on whether the sample is arterial or venous, whether the patient is at rest or provoked, and whether the measurement is end-tidal, transcutaneous or directly sampled blood.
Sleep studies can identify obstructive sleep apnea, central events, oxygen desaturation and sleep architecture, but a conventional polysomnogram may not capture the subjective difficulty of falling asleep because nasal airflow no longer feels normal. A normal apnea–hypopnea index therefore does not automatically mean that a patient sleeps well. At the same time, an actual sleep disorder should not be attributed to ENS without evaluating it.
The cotton test occupies a different role from all of these methods because it is a functional provocation. Rather than asking what the cavity looks like, it asks whether temporarily restoring local volume changes the patient’s ENS-specific symptoms. When combined with the ENS6Q and a careful clinical history, it provides information that anatomy alone cannot.
Newer blinded approaches are valuable because expectation effects are real in every symptom-based field. The SENSE study found a placebo response in some ENS patients, but it also found substantially stronger responses to specific cotton placements, especially in the inferior meatus. That pattern supports using better test design rather than abandoning symptom-based evaluation.
The practical lesson is that no single result should dominate the diagnosis. ENS assessment works best when structural findings, characteristic symptoms, validated questionnaires and functional testing tell a coherent story. When they do not, clinicians should remain open to alternative or additional diagnoses rather than forcing every postoperative breathing complaint into the ENS label.
Symptoms and daily impact
ENS can be far more than a sensation of nasal blockage. The validated ENS6Q was developed around six symptoms that are particularly useful for distinguishing ENS from ordinary obstructive nasal disease: nasal suffocation, nasal burning, excessive openness, crusting, dryness and impaired sensation of airflow through the nasal cavities. Individual patients may emphasize different parts of this cluster.
Dryness is often especially prominent because an enlarged or aerodynamically altered cavity can expose remaining mucosa to a different pattern of air movement. Some patients describe burning, cold sensitivity or painful rawness rather than simple dryness. Crusting can develop when hydration and mucociliary conditions are impaired. Others describe the nose as simultaneously “too open” and “blocked,” a combination that sounds contradictory until sensory airflow perception is considered.
Air hunger is another important complaint. Patients may say that they can inhale air but do not receive the normal feeling of a satisfying breath. This can lead to repeated sighing, conscious monitoring of breathing, faster breathing or difficulty allowing respiration to become automatic during rest. The experience can be exhausting and can interfere with conversation, concentration, exercise and sleep.
Many patient reports also describe environmental sensitivity. Dry heated rooms, air conditioning, cold moving air, smoke, dust, fragrances or other irritants may worsen symptoms. This is not identical in every patient: some prefer cool air because it strengthens nasal sensation, while others experience cold air as painful. Humidity is similarly individual, although many people with prominent dryness report relief in more humid conditions.
The functional consequences can become substantial. Severe cases describe difficulty sleeping, working, studying, travelling, speaking for long periods or remaining in environments whose humidity and airflow cannot be controlled. These limitations are documented in quality-of-life research, but the severity spectrum is broad. ENS should therefore not be portrayed as inevitably catastrophic; it can range from troublesome to profoundly disabling.
Breathing regulation, air hunger and hyperventilation
Some ENS patients report a striking change in breathing regulation: respiration feels faster, shallower or more consciously driven, and the normal sense of an effortless automatic breath is lost. This is an area where the evidence is clinically important but must be described carefully.
A prospective study of patients referred for ENS investigated hyperventilation syndrome using the Nijmegen questionnaire, a hyperventilation provocation test, end-tidal carbon dioxide and other cardiopulmonary measurements. Twenty-two of 29 referred patients completed the full workup, and hyperventilation syndrome was diagnosed in 17 of those 22, or 77.3%. A small subgroup that completed a respiratory rehabilitation program showed improvement in sinonasal symptom scores. The investigators concluded that hyperventilation syndrome appeared frequent in their ENS cohort and that the pathophysiological relationship deserved further study.
This study does not mean that 77.3% of all people with ENS have chronic hypocapnia, nor that hyperventilation explains the entire syndrome. It was a relatively small referred cohort, and the diagnosis was based on the study’s provocation-test criteria. Still, it is important evidence that disordered breathing regulation can coexist with ENS and may be a meaningful treatment target in selected patients.
When ventilation exceeds metabolic need, carbon dioxide can fall and respiratory alkalosis can occur. General respiratory physiology shows that marked hypocapnia can contribute to dizziness, tingling, muscle symptoms and changes in cerebral blood flow. What has not been established is that every ENS patient has chronic respiratory alkalosis or that ENS routinely causes broad organ damage through low carbon dioxide. Those stronger claims require patient-specific measurements and more research.
Breathing rehabilitation may therefore be relevant for some patients, but it should not be framed as proof that ENS is “just hyperventilation.” A useful clinical model is that abnormal nasal sensory feedback may interact with respiratory control, anxiety, attention and learned breathing patterns. The relative importance of each component can differ from one person to another.
See the dedicated Swedish research summary: Hyperventilationssyndrom vid Empty Nose Syndrome: 17 av 22 patienter i en prospektiv studie.
Sleep, fatigue and cognitive function
Sleep disturbance is one of the most consequential complaints reported by many ENS patients. A person who is continuously aware of abnormal nasal breathing may find it difficult to transition from wakefulness into sleep. Dryness, burning or air hunger can also produce repeated awakenings. Over time, fragmented sleep can amplify pain sensitivity, emotional reactivity, fatigue and cognitive difficulty.
Research on ENS and sleep has reported relationships between sleep dysfunction and psychological burden. The direction of causality is unlikely to be simple. Poor sleep can worsen anxiety and depression; severe breathing discomfort can worsen sleep; psychological hyperarousal can in turn make bodily sensations harder to ignore. A circular model is often more realistic than attributing everything to a single cause.
Patients sometimes describe reduced concentration, memory difficulty or a sense of mental exhaustion. These complaints should be taken seriously, while also recognizing that several mechanisms can contribute: chronic sleep loss, persistent pain, respiratory discomfort, medication effects, mood symptoms and the cognitive load of continuously monitoring breathing.
The practical implication is that sleep should be assessed directly rather than treated as a minor secondary symptom. Depending on the presentation, clinicians may need to consider ordinary sleep disorders as well as ENS-related factors. Not every nighttime problem in a person with ENS is necessarily caused by ENS, and treating a coexisting sleep disorder can still provide meaningful benefit even when nasal symptoms remain.
Psychological burden without psychologizing ENS
ENS research consistently reports a high burden of anxiety, depression and psychological distress in affected cohorts. This has sometimes created an unhelpful false choice: either ENS is a physical postoperative disorder or the symptoms are psychological. The evidence does not require that dichotomy.
A person can have altered nasal airflow and sensory physiology and develop anxiety because breathing feels unsafe or incomplete. Persistent insomnia, pain, loss of function and difficulty obtaining a diagnosis can further increase psychological distress. Conversely, anxiety and hypervigilance can amplify awareness of breathing sensations and make symptom regulation more difficult. These processes can coexist and reinforce one another.
Functional neuroimaging research has reported altered activation in brain regions involved in emotional processing during nasal breathing in ENS patients. This should not be interpreted as evidence that the disorder is imaginary. All perception, including pain and breathing sensation, is processed by the brain. Neuroimaging findings are more appropriately understood as evidence that ENS affects how respiratory sensory information is processed.
Because the mental-health burden can be substantial, assessment and treatment of depression, anxiety, trauma reactions or severe insomnia can be an important part of comprehensive care. Psychological treatment should be offered as support for a difficult physical condition, not as a substitute for evaluating nasal physiology. Likewise, severe psychological symptoms should not be used to dismiss reports of postoperative nasal dysfunction.
Nasal surgery, turbinate reduction and ENS risk
ENS is most strongly associated with turbinate surgery, particularly substantial reduction or resection of the inferior turbinates. Historical descriptions focused on total or near-total turbinectomy, but ENS-like symptoms have also been reported after less extensive procedures. At the same time, the majority of people undergoing modern turbinate surgery do not develop ENS.
This is an important point for informed discussion. A website about ENS should neither minimize the complication nor imply that every turbinate procedure predictably causes it. The available evidence does not provide a precise individual risk percentage that can be applied to all techniques, surgeons and patient populations. Studies also suggest that anatomy alone does not reliably separate ENS from asymptomatic people who have undergone turbinate reduction.
The type of operation matters because different techniques preserve different amounts of mucosa, bone and submucosal vascular tissue. Modern approaches often aim for mucosal preservation and conservative volume reduction. The broad preventive principle supported across reviews is to avoid excessive turbinate tissue loss and to preserve functional nasal anatomy whenever possible.
Septoplasty is different from turbinate reduction: its purpose is to correct the nasal septum rather than remove turbinate tissue. Nevertheless, many operations combine septoplasty with turbinate procedures, making patient histories difficult to interpret from the word “septoplasty” alone. Rare reports also discuss ENS-type symptoms after other intranasal procedures. When reviewing an individual case, the actual operative report is more informative than the procedure label used in casual conversation.
Preoperative evaluation should consider other explanations for nasal obstruction, such as inflammatory rhinitis, allergy, chronic rhinosinusitis, nasal valve dysfunction or medication-related congestion. A deviated septum or enlarged turbinate on imaging does not automatically establish that surgery is required; symptoms, examination findings and response to appropriate medical treatment also matter. The purpose of this point is not to discourage needed surgery, but to support careful selection and realistic informed consent.
For patients considering an operation, see Empty Nose Syndrome and Nasal Surgery: What to Understand Before Surgery.
How Empty Nose Syndrome is diagnosed
There is no single blood test or scan that proves ENS. Diagnosis is clinical and usually combines the postoperative history, characteristic symptoms, nasal examination and structured symptom testing. This is one reason evaluation is best performed by a rhinologist or other clinician familiar with ENS rather than by relying on cavity size alone.
ENS6Q
The Empty Nose Syndrome 6-Item Questionnaire is a validated symptom instrument focused on six characteristic complaints: suffocation, burning, excessive openness, crusting, dryness and impaired airflow sensation. A later diagnostic study commonly used a score of 11 or greater as a threshold for suspected ENS in combination with clinical assessment. The questionnaire is not a stand-alone diagnosis, but it provides a standardized way to quantify the symptom pattern.
Cotton test
In the classic office cotton test, small cotton pledgets are placed temporarily in the region of missing inferior turbinate tissue. A meaningful reduction in ENS6Q symptoms while the cotton is in place supports the idea that restoring local volume or redirecting airflow may help. Validation work established a roughly seven-point ENS6Q change as clinically meaningful.
Because expectation can influence symptom reporting, newer work has introduced a stepwise, blinded version known as the SENSE test. In a 48-patient study, responses differed depending on where cotton was placed, and a measurable placebo response was also observed. That finding does not invalidate the cotton test; it shows why standardized, blinded testing can improve diagnostic confidence and help identify the location most likely to benefit from augmentation.
Endoscopy, imaging and functional assessment
Nasal endoscopy helps document remaining turbinate tissue, mucosal condition, crusting, scar, valve problems and other structural findings. CT can be useful for anatomy and surgical planning, but a wide cavity on CT is not synonymous with ENS. Some specialized centers also use computational airflow analysis, trigeminal sensory testing or other physiological methods, although these are not routine diagnostic requirements everywhere.
The diagnostic process should also look for conditions that can mimic or add to ENS symptoms: nasal valve collapse, inflammatory rhinitis, sinus disease, neuropathic pain, asthma, dysfunctional breathing and sleep disorders. More than one problem can be present at the same time.
For a focused clinical summary, see Diagnos och behandling av Empty Nose Syndrome: klinisk översikt av Chhabra och Houser.
Treatment and symptom management
No single treatment reliably resolves ENS for every patient. Management is usually individualized and often combines measures aimed at mucosal comfort, airflow, breathing regulation, sleep and psychological burden. The evidence base is growing but remains limited by small studies, heterogeneous techniques and a lack of large randomized controlled trials.
Humidification and mucosal care
Saline irrigation or spray, humidification and moisturizing preparations are commonly used first-line strategies, especially when dryness and crusting dominate. The exact product should be chosen with attention to tolerance and medical advice. Overly aggressive irrigation or irritating additives can worsen symptoms in some people, so more is not always better.
Temporary airflow modification
The diagnostic cotton test illustrates that temporarily adding volume can improve symptoms in selected patients. Some patients use clinician-guided nasal inserts or plugs to alter airflow. Newer research has also explored customized three-dimensional printed devices. These approaches can be useful for testing whether airflow redirection is likely to help before permanent surgery is considered.
Breathing rehabilitation
For patients with documented or suspected dysfunctional breathing, respiratory physiotherapy may be useful. The small ENS hyperventilation study described earlier reported symptom improvement among the few participants who completed an eight-session breathing rehabilitation program. This is not a cure for missing tissue, but it may reduce one amplifying component of the symptom complex.
Sleep, pain and mental-health treatment
Treating associated insomnia, neuropathic pain, anxiety or depression can improve overall function even when nasal symptoms persist. This should be integrated with — not substituted for — nasal assessment. Some patients require multidisciplinary care involving rhinology, sleep medicine, pain management, respiratory physiotherapy and psychological support.
Emerging conservative approaches
Recent reviews discuss temporary fillers, sensory or trigeminal training approaches and other non-permanent interventions. Evidence for these remains less mature than for established diagnostic tools and commonly reported reconstruction techniques. Patients should distinguish promising early reports from treatments supported by large comparative trials.
Reconstructive surgery and implants
When symptoms are severe, conservative measures are insufficient and cotton testing indicates that restoring volume may help, surgical augmentation can be considered. The goal is not to recreate the original turbinate perfectly — which current surgery cannot do — but to add volume at a strategically chosen location so airflow is redistributed and interaction with mucosa improves.
Inferior meatus augmentation is among the most frequently reported approaches. Different centers use different materials, including autologous cartilage, acellular dermal materials and synthetic implants. Comparative evidence has not established one material as universally superior. Each option has trade-offs involving availability, resorption, rigidity, infection risk, extrusion, donor-site morbidity and long-term stability.
Patient selection is crucial. A positive cotton or SENSE test can help identify whether temporary augmentation improves symptoms and where the effect is strongest. Reconstruction tends to be described as symptom-improving rather than curative. Some studies report meaningful improvements in ENS6Q, SNOT scores, anxiety and depression after surgery, while individual outcomes remain variable.
A 2024 systematic review and meta-analysis of management strategies included 35 articles and 957 individual ENS patients. Most of the intervention literature involved surgical augmentation. Pooled outcomes showed improvement across ENS6Q, SNOT, anxiety and depression measures, but the authors emphasized the limited evidence base and absence of randomized controlled trials. That is a useful summary of the current situation: reconstruction is a serious treatment option, but certainty about the best technique and long-term comparative effectiveness remains incomplete.
See Empty Nose Syndrome Reconstruction: Comparing Cartilage, Medpor and Other Implant Materials for a dedicated comparison.
What research supports — and what remains uncertain
Relatively well supported
ENS is a recognized postoperative syndrome characterized by paradoxical obstruction and impaired airflow sensation; validated symptom tools exist; cotton augmentation can improve symptoms in selected patients; altered airflow and trigeminal sensory function are important research themes.
Supported, but heterogeneous
Dryness, sleep disturbance, psychological burden, hyperventilation in a subgroup, histopathological changes, altered nasal nitric oxide and benefit from reconstructive surgery have all been reported, but not uniformly in every patient.
Not established as universal ENS effects
Chronic systemic hypoxia, inevitable respiratory alkalosis, routine kidney damage, universally reduced cardiac output or a fixed autonomic pattern should not be presented as proven consequences of ENS without patient-specific evidence.
This distinction matters because the older internet discussion of ENS sometimes moved from a plausible physiological mechanism to certainty too quickly. For example, low nasal resistance can influence breathing mechanics and perception, but it does not follow that every person with an open postoperative cavity will chronically hyperventilate. Likewise, general physiology tells us that severe hypocapnia affects cerebral blood flow and acid-base balance, but proving that mechanism in an individual ENS patient requires actual respiratory or blood-gas measurements.
The same caution applies in the opposite direction. Lack of a dramatic abnormality on routine CT, rhinomanometry or oxygen saturation does not establish that a patient’s symptoms are psychological. ENS research specifically arose because conventional anatomical measures often fail to capture the subjective and sensory disorder. The best interpretation is therefore evidence-based and patient-specific rather than dismissive in either direction.
Where ENS research is heading
ENS research has moved from descriptive case reports toward validated questionnaires, standardized provocation tests, computational fluid dynamics, sensory testing, histopathology, neuroimaging and treatment meta-analysis. That progression is important because it makes the condition increasingly measurable even though no single biomarker has emerged.
One major research goal is to understand susceptibility. If many people undergo turbinate procedures but only a minority develop ENS, what differentiates the affected group? Candidate factors include baseline trigeminal sensitivity, the exact airflow pattern created by surgery, mucosal healing, neural regeneration, inflammatory responses, pre-existing nasal physiology and central processing of respiratory sensation.
Another goal is better treatment selection. A future patient may be evaluated not only with an ENS6Q score and cotton test but with individualized airflow simulation and location-specific sensory testing to determine where augmentation would most likely help. The newer SENSE approach is already an example of making a subjective office test more standardized and less vulnerable to expectation effects.
Treatment research also needs stronger comparative designs. Many published series report favorable outcomes from implants or other interventions, but small observational studies can overestimate benefit and make it difficult to compare materials. Prospective multicenter registries, standardized outcome measures and randomized or blinded components where feasible would improve the evidence considerably.
For readers who want to go directly to the scientific literature, the site’s Empty Nose Syndrome Research Library organizes studies by mechanism, diagnosis, functional impact and treatment.
Frequently asked questions
Is ENS the same as ordinary nasal obstruction?
No. Conventional obstruction usually involves narrowing that increases resistance. ENS is characterized by the paradox that the airway can be objectively open while the person experiences obstruction, suffocation or inadequate airflow sensation. Other disorders can coexist, however, so a person with ENS can also have nasal valve collapse, septal deviation, rhinitis or sinus disease.
Does every turbinate reduction cause ENS?
No. Most people who undergo turbinate procedures do not develop ENS. Risk appears to depend on more than the amount of tissue removed. Preserving mucosa and avoiding excessive resection are important preventive principles, but current research cannot provide a simple formula that predicts the outcome for an individual patient.
Can ENS occur after septoplasty?
ENS is primarily associated with turbinate tissue loss. Many patients, however, undergo septoplasty and turbinate reduction during the same operation, so a history described simply as “septoplasty” may conceal a simultaneous turbinate procedure. ENS-like symptoms have also been reported after other nasal operations, but the operative details matter.
Why does cotton help if the nose is already open?
Because the goal is not merely to add resistance. Cotton can redirect the stream of air toward different mucosal surfaces, increase local air-mucosa interaction and temporarily reproduce some of the volume that was lost. The symptom response can therefore provide information about whether permanent augmentation might help.
Is ENS caused by nerve damage?
Abnormal trigeminal sensory function is one of the strongest mechanistic themes, but “nerve damage” is too simple as a universal explanation. Research suggests an interaction between sensory function, mucosal cooling, airflow distribution and tissue changes. Different patients may arrive at similar symptoms through somewhat different combinations of these factors.
Can ENS cause hyperventilation?
It can be associated with hyperventilation syndrome in some patients. In one prospective referred cohort, 17 of 22 fully evaluated patients met the study criteria for HVS. The result is important but cannot be generalized into a claim that all ENS patients are chronically hypocapnic.
Is ENS psychological?
ENS is studied as a postoperative nasal syndrome with measurable differences in sensory function and airflow. Psychological distress is also common and clinically important. Treating anxiety, depression or insomnia does not mean the nasal symptoms are imaginary; it addresses part of the total burden of the disorder.
Is there a cure?
There is currently no single universally curative treatment. Some patients improve with conservative measures, respiratory rehabilitation or management of associated conditions. Carefully selected patients can experience substantial improvement from augmentation surgery, but outcomes vary and restoration of the original turbinate organ is not currently possible.
What should a person do if they suspect ENS?
Document the surgical history, obtain the operative report when possible, and seek assessment from a clinician familiar with ENS. A structured evaluation with ENS6Q, nasal examination and cotton-based testing is more informative than relying only on CT appearance. Symptoms such as severe dyspnea, chest pain, syncope or acute medical deterioration should still be evaluated on their own merits rather than automatically attributed to ENS.
Key research sources
- Empty Nose Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment — narrative review covering more than 70 publications.
- Empty Nose Syndrome Pathophysiology: A Systematic Review — systematic review of original pathophysiology studies.
- Sozansky & Houser: Empty Nose Syndrome efter näsmusselkirurgi: luftflödeskänsla och neurosensorisk patofysiologi — influential review of nasal airflow sensation and neurosensory mechanisms.
- Computational fluid dynamics and trigeminal sensory examinations of ENS patients — airflow redistribution and impaired menthol detection.
- The Empty Nose Syndrome 6-Item Questionnaire (ENS6Q) — validation of the ENS-specific symptom instrument.
- Validation of the office-based cotton test and ENS6Q clinical interpretability.
- Stepwise Empty Nose Syndrome Evaluation (SENSE) test — blinded, location-specific modification of cotton testing.
- Investigating hyperventilation syndrome in patients suffering from ENS.
- Systematic review and meta-analysis of ENS management options.
- American Rhinologic Society position statements — includes the joint ENS position statement.
This page is educational and does not replace individual medical assessment. Because ENS research is developing, conclusions are stated according to the strength of the available evidence rather than as universal rules.
Inga kommentarer:
Skicka en kommentar